Li 2007.

Methods	Randomised parallel group controlled trial
Participants	Target sample size: 52; age minimum: 6; age maximum: 18
Interventions	Intranasal mometasone furoate versus placebo
Outcomes	"The primary outcome is the change from baseline the various respiratory parameters as documented by overnight polysomnography after a 4‐month treatment. The secondary outcome is the change from baseline the adenoidal size as assessed by standardized lateral neck radiograph after a 4‐month treatment."
Notes	"Source of funding: Departmental" "Recruiting status: completed" (last update: 31 May 2015)